Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Molecular Pathways of Neurodegeneration in Parkinson's Disease
Ted M. Dawson1,2,3* and
Valina L. Dawson1,2,3,4
Parkinson's disease (PD) is a complex disorder with many differentcauses, yet they may intersect in common pathways, raising thepossibility that neuroprotective agents may have broad applicabilityin the treatment of PD. Current evidence suggests that mitochondrialcomplex I inhibition may be the central cause of sporadic PDand that derangements in complex I cause -synuclein aggregation,which contributes to the demise of dopamine neurons. Accumulationand aggregation of -synuclein may further contribute to thedeath of dopamine neurons through impairments in protein handlingand detoxification. Dysfunction of parkin (a ubiquitin E3 ligase)and DJ-1 could contribute to these deficits. Strategies aimedat restoring complex I activity, reducing oxidative stress and-synuclein aggregation, and enhancing protein degradation mayhold particular promise as powerful neuroprotective agents inthe treatment of PD.
1 Institute for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA. 2 Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA. 3 Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA. 4 Department of Physiology, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.
* To whom correspondence should be addressed. E-mail: tdawson{at}jhmi.edu
The editors suggest the following Related Resources on Science sites:
In Science Magazine
INTRODUCTION TO SPECIAL ISSUE
Peter Stern and Laura Helmuth (31 October 2003) Science302 (5646), 807.
[DOI: 10.1126/science.302.5646.807] |Summary »|PDF »
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
A Sporadic Parkinson Disease Model via Silencing of the Ubiquitin-Proteasome/E3 Ligase Component SKP1A.
T. Fishman-Jacob, L. Reznichenko, M. B. H. Youdim, and S. A. Mandel (2009)
J. Biol. Chem.
284, 32835-32845
|Abstract »|Full Text »|PDF »
Parkin selectively alters the intrinsic threshold for mitochondrial cytochrome c release.
A. K. Berger, G. P. Cortese, K. D. Amodeo, A. Weihofen, A. Letai, and M. J. LaVoie (2009)
Hum. Mol. Genet.
18, 4317-4328
|Abstract »|Full Text »|PDF »
Longitudinal progression of sporadic Parkinson's disease: a multi-tracer positron emission tomography study.
R. Nandhagopal, L. Kuramoto, M. Schulzer, E. Mak, J. Cragg, C. S. Lee, J. McKenzie, S. McCormick, A. Samii, A. Troiano, et al. (2009)
Brain
132, 2970-2979
|Abstract »|Full Text »|PDF »
Structural Basis for the Mechanism of Respiratory Complex I.
M. P. Burns, L. Zhang, G. W. Rebeck, H. W. Querfurth, and C. E.-H. Moussa (2009)
Hum. Mol. Genet.
18, 3206-3216
|Abstract »|Full Text »|PDF »
Proteasome Inactivation Promotes p38 Mitogen-activated Protein Kinase-dependent Phosphatidylinositol 3-kinase Activation and Increases Interleukin-8 Production in Retinal Pigment Epithelial Cells.
A. F. Fernandes, Q. Bian, J.-K. Jiang, C. J. Thomas, A. Taylor, P. Pereira, and F. Shang (2009)
Mol. Biol. Cell
20, 3690-3699
|Abstract »|Full Text »|PDF »
From the Cover: Inclusion formation and neuronal cell death through neuron-to-neuron transmission of {alpha}-synuclein.
P. Desplats, H.-J. Lee, E.-J. Bae, C. Patrick, E. Rockenstein, L. Crews, B. Spencer, E. Masliah, and S.-J. Lee (2009)
PNAS
106, 13010-13015
|Abstract »|Full Text »|PDF »
The Homocysteine-inducible Endoplasmic Reticulum Stress Protein Counteracts Calcium Store Depletion and Induction of CCAAT Enhancer-binding Protein Homologous Protein in a Neurotoxin Model of Parkinson Disease.
S. Chigurupati, Z. Wei, C. Belal, M. Vandermey, G. A. Kyriazis, T. V. Arumugam, and S. L. Chan (2009)
J. Biol. Chem.
284, 18323-18333
|Abstract »|Full Text »|PDF »
Evaluation of Blastomere Biopsy Using a Mouse Model Indicates the Potential High Risk of Neurodegenerative Disorders in the Offspring.
Y. Yu, J. Wu, Y. Fan, Z. Lv, X. Guo, C. Zhao, R. Zhou, Z. Zhang, F. Wang, M. Xiao, et al. (2009)
Mol. Cell. Proteomics
8, 1490-1500
|Abstract »|Full Text »|PDF »
Omi is a mammalian heat-shock protein that selectively binds and detoxifies oligomeric amyloid-{beta}.
M.-L. Liu, M.-J. Liu, Y.-F. Shen, H. Ryu, H.-J. Kim, K. Klupsch, J. Downward, and S.-T. Hong (2009)
J. Cell Sci.
122, 1917-1926
|Abstract »|Full Text »|PDF »
The scientific and clinical basis for the treatment of Parkinson disease (2009).
Loss of PINK1 Function Promotes Mitophagy through Effects on Oxidative Stress and Mitochondrial Fission.
R. K. Dagda, S. J. Cherra III, S. M. Kulich, A. Tandon, D. Park, and C. T. Chu (2009)
J. Biol. Chem.
284, 13843-13855
|Abstract »|Full Text »|PDF »
Synaptic Activity-Mediated Suppression of p53 and Induction of Nuclear Calcium-Regulated Neuroprotective Genes Promote Survival through Inhibition of Mitochondrial Permeability Transition.
S-nitrosylation of XIAP compromises neuronal survival in Parkinson's disease.
A. H. K. Tsang, Y.-I. Lee, H. S. Ko, J. M. Savitt, O. Pletnikova, J. C. Troncoso, V. L. Dawson, T. M. Dawson, and K. K. K. Chung (2009)
PNAS
106, 4900-4905
|Abstract »|Full Text »|PDF »
CHIP regulates leucine-rich repeat kinase-2 ubiquitination, degradation, and toxicity.
H. S. Ko, R. Bailey, W. W. Smith, Z. Liu, J.-H. Shin, Y.-I. Lee, Y.-J. Zhang, H. Jiang, C. A. Ross, D. J. Moore, et al. (2009)
PNAS
106, 2897-2902
|Abstract »|Full Text »|PDF »
Nrf2-mediated neuroprotection in the MPTP mouse model of Parkinson's disease: Critical role for the astrocyte.
P.-C. Chen, M. R. Vargas, A. K. Pani, R. J. Smeyne, D. A. Johnson, Y. W. Kan, and J. A. Johnson (2009)
PNAS
106, 2933-2938
|Abstract »|Full Text »|PDF »
Bacterial Artificial Chromosome Transgenic Mice Expressing a Truncated Mutant Parkin Exhibit Age-Dependent Hypokinetic Motor Deficits, Dopaminergic Neuron Degeneration, and Accumulation of Proteinase K-Resistant {alpha}-Synuclein.
X.-H. Lu, S. M. Fleming, B. Meurers, L. C. Ackerson, F. Mortazavi, V. Lo, D. Hernandez, D. Sulzer, G. R. Jackson, N. T. Maidment, et al. (2009)
J. Neurosci.
29, 1962-1976
|Abstract »|Full Text »|PDF »
Inaugural Article: A mouse forward genetics screen identifies LISTERIN as an E3 ubiquitin ligase involved in neurodegeneration.
J. Chu, N. A. Hong, C. A. Masuda, B. V. Jenkins, K. A. Nelms, C. C. Goodnow, R. J. Glynne, H. Wu, E. Masliah, C. A. P. Joazeiro, et al. (2009)
PNAS
106, 2097-2103
|Abstract »|Full Text »|PDF »
Reactive Oxygen Species Regulate Ceruloplasmin by a Novel mRNA Decay Mechanism Involving Its 3'-Untranslated Region: IMPLICATIONS IN NEURODEGENERATIVE DISEASES.
N. Tapryal, C. Mukhopadhyay, D. Das, P. L. Fox, and C. K. Mukhopadhyay (2009)
J. Biol. Chem.
284, 1873-1883
|Abstract »|Full Text »|PDF »
Pruning and loss of excitatory synapses by the parkin ubiquitin ligase.
T. D. Helton, T. Otsuka, M.-C. Lee, Y. Mu, and M. D. Ehlers (2008)
PNAS
105, 19492-19497
|Abstract »|Full Text »|PDF »
Novel suppressors of {alpha}-synuclein toxicity identified using yeast.
J. Liang, C. Clark-Dixon, S. Wang, T. R. Flower, T. Williams-Hart, R. Zweig, L. C. Robinson, K. Tatchell, and S. N. Witt (2008)
Hum. Mol. Genet.
17, 3784-3795
|Abstract »|Full Text »|PDF »
Mitochondrial Complex I Inhibitor Rotenone Inhibits and Redistributes Vesicular Monoamine Transporter 2 via Nitration in Human Dopaminergic SH-SY5Y Cells.
Mitochondrial complex I inhibition is not required for dopaminergic neuron death induced by rotenone, MPP+, or paraquat.
W.-S. Choi, S. E. Kruse, R. D. Palmiter, and Z. Xia (2008)
PNAS
105, 15136-15141
|Abstract »|Full Text »|PDF »
Serine 129 Phosphorylation of {alpha}-Synuclein Induces Unfolded Protein Response-mediated Cell Death.
N. Sugeno, A. Takeda, T. Hasegawa, M. Kobayashi, A. Kikuchi, F. Mori, K. Wakabayashi, and Y. Itoyama (2008)
J. Biol. Chem.
283, 23179-23188
|Abstract »|Full Text »|PDF »
Electrophysiology and Pharmacology of Striatal Neuronal Dysfunction Induced by Mitochondrial Complex I Inhibition.
C. Costa, V. Belcastro, A. Tozzi, M. Di Filippo, M. Tantucci, S. Siliquini, A. Autuori, B. Picconi, M. G. Spillantini, E. Fedele, et al. (2008)
J. Neurosci.
28, 8040-8052
|Abstract »|Full Text »|PDF »
Oxidative Inactivation of the Proteasome in Retinal Pigment Epithelial Cells: A POTENTIAL LINK BETWEEN OXIDATIVE STRESS AND UP-REGULATION OF INTERLEUKIN-8.
A. F. Fernandes, J. Zhou, X. Zhang, Q. Bian, J. Sparrow, A. Taylor, P. Pereira, and F. Shang (2008)
J. Biol. Chem.
283, 20745-20753
|Abstract »|Full Text »|PDF »
{alpha}-Synuclein Protofibrils Inhibit 26 S Proteasome-mediated Protein Degradation: UNDERSTANDING THE CYTOTOXICITY OF PROTEIN PROTOFIBRILS IN NEURODEGENERATIVE DISEASE PATHOGENESIS.
N.-Y. Zhang, Z. Tang, and C.-W. Liu (2008)
J. Biol. Chem.
283, 20288-20298
|Abstract »|Full Text »|PDF »
Quantitative Proteomics of a Presymptomatic A53T {alpha}-Synuclein Drosophila Model of Parkinson Disease.
Z. Xun, R. A. Sowell, T. C. Kaufman, and D. E. Clemmer (2008)
Mol. Cell. Proteomics
7, 1191-1203
|Abstract »|Full Text »|PDF »
Genotype-phenotype correlations between GBA mutations and Parkinson disease risk and onset.
Z. Gan-Or, N. Giladi, U. Rozovski, C. Shifrin, S. Rosner, T. Gurevich, A. Bar-Shira, and A. Orr-Urtreger (2008)
Neurology
70, 2277-2283
|Abstract »|Full Text »|PDF »
Pink1 regulates mitochondrial dynamics through interaction with the fission/fusion machinery.
Y. Yang, Y. Ouyang, L. Yang, M. F. Beal, A. McQuibban, H. Vogel, and B. Lu (2008)
PNAS
105, 7070-7075
|Abstract »|Full Text »|PDF »
Use of antihypertensives and the risk of Parkinson disease.
Mitochondrial Import and Accumulation of {alpha}-Synuclein Impair Complex I in Human Dopaminergic Neuronal Cultures and Parkinson Disease Brain.
L. Devi, V. Raghavendran, B. M. Prabhu, N. G. Avadhani, and H. K. Anandatheerthavarada (2008)
J. Biol. Chem.
283, 9089-9100
|Abstract »|Full Text »|PDF »
Ubiquitination of {alpha}-synuclein by Siah-1 promotes {alpha}-synuclein aggregation and apoptotic cell death.
J. T. Lee, T. C. Wheeler, L. Li, and L.-S. Chin (2008)
Hum. Mol. Genet.
17, 906-917
|Abstract »|Full Text »|PDF »
{alpha}-Synuclein Aggregates Interfere with Parkin Solubility and Distribution: ROLE IN THE PATHOGENESIS OF PARKINSON DISEASE.
K. Kawahara, M. Hashimoto, P. Bar-On, G. J. Ho, L. Crews, H. Mizuno, E. Rockenstein, S. Z. Imam, and E. Masliah (2008)
J. Biol. Chem.
283, 6979-6987
|Abstract »|Full Text »|PDF »
Hypothesis-based RNAi screening identifies neuroprotective genes in a Parkinson's disease model.
S. Hamamichi, R. N. Rivas, A. L. Knight, S. Cao, K. A. Caldwell, and G. A. Caldwell (2008)
PNAS
105, 728-733
|Abstract »|Full Text »|PDF »
Induction of the Phase II Detoxification Pathway Suppresses Neuron Loss in Drosophila Models of Parkinson's Disease.
K. Trinh, K. Moore, P. D. Wes, P. J. Muchowski, J. Dey, L. Andrews, and L. J. Pallanck (2008)
J. Neurosci.
28, 465-472
|Abstract »|Full Text »|PDF »
Extracellular ATP Mediates Necrotic Cell Swelling in SN4741 Dopaminergic Neurons through P2X7 Receptors.
D.-J. Jun, J. Kim, S.-Y. Jung, R. Song, J.-H. Noh, Y.-S. Park, S.-H. Ryu, J.-H. Kim, Y.-Y. Kong, J.-M. Chung, et al. (2007)
J. Biol. Chem.
282, 37350-37358
|Abstract »|Full Text »|PDF »
Nitric Oxide and Mitochondrial Signaling: From Physiology to Pathophysiology.
J. D. Erusalimsky and S. Moncada (2007)
Arterioscler Thromb Vasc Biol
27, 2524-2531
|Abstract »|Full Text »|PDF »
Methionine Sulfoxide Reductase A and a Dietary Supplement S-Methyl-L-Cysteine Prevent Parkinson's-Like Symptoms.
R. Wassef, R. Haenold, A. Hansel, N. Brot, S. H. Heinemann, and T. Hoshi (2007)
J. Neurosci.
27, 12808-12816
|Abstract »|Full Text »|PDF »
Mitochondrial Complex I Inhibitor Rotenone-Elicited Dopamine Redistribution from Vesicles to Cytosol in Human Dopaminergic SH-SY5Y Cells.
YGR198w (YPP1) targets A30P {alpha}-synuclein to the vacuole for degradation.
T. R. Flower, C. Clark-Dixon, C. Metoyer, H. Yang, R. Shi, Z. Zhang, and S. N. Witt (2007)
J. Cell Biol.
177, 1091-1104
|Abstract »|Full Text »|PDF »
Multifunctional tellurium molecule protects and restores dopaminergic neurons in Parkinson's disease models.
B. Sredni, R. Geffen-Aricha, W. Duan, M. Albeck, F. Shalit, H. M. Lander, N. Kinor, O. Sagi, A. Albeck, S. Yosef, et al. (2007)
FASEB J
21, 1870-1883
|Abstract »|Full Text »|PDF »
Assembly of Lysine 63-linked Ubiquitin Conjugates by Phosphorylated {alpha}-Synuclein Implies Lewy Body Biogenesis.
C. Liu, E. Fei, N. Jia, H. Wang, R. Tao, A. Iwata, N. Nukina, J. Zhou, and G. Wang (2007)
J. Biol. Chem.
282, 14558-14566
|Abstract »|Full Text »|PDF »
Activation of c-Jun N-Terminal Protein Kinase Is a Common Mechanism Underlying Paraquat- and Rotenone-Induced Dopaminergic Cell Apoptosis.
H. Klintworth, K. Newhouse, T. Li, W.-S. Choi, R. Faigle, and Z. Xia (2007)
Toxicol. Sci.
97, 149-162
|Abstract »|Full Text »|PDF »
Calpain-Cleavage of {alpha}-Synuclein: Connecting Proteolytic Processing to Disease-Linked Aggregation.
B. M. Dufty, L. R. Warner, S. T. Hou, S. X. Jiang, T. Gomez-Isla, K. M. Leenhouts, J. T. Oxford, M. B. Feany, E. Masliah, and T. T. Rohn (2007)
Am. J. Pathol.
170, 1725-1738
|Abstract »|Full Text »|PDF »
Extended polyglutamine repeats trigger a feedback loop involving the mitochondrial complex III, the proteasome and huntingtin aggregates.
Divergent Mechanisms of Paraquat, MPP+, and Rotenone Toxicity: Oxidation of Thioredoxin and Caspase-3 Activation.
S. Ramachandiran, J. M. Hansen, D. P. Jones, J. R. Richardson, and G. W. Miller (2007)
Toxicol. Sci.
95, 163-171
|Abstract »|Full Text »|PDF »
Obligatory Role for Complex I Inhibition in the Dopaminergic Neurotoxicity of 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
J. R. Richardson, W. M. Caudle, T. S. Guillot, J. L. Watson, E. Nakamaru-Ogiso, B. B. Seo, T. B. Sherer, J. T. Greenamyre, T. Yagi, A. Matsuno-Yagi, et al. (2007)
Toxicol. Sci.
95, 196-204
|Abstract »|Full Text »|PDF »
Role of cardiolipin alterations in mitochondrial dysfunction and disease.
A. J. Chicco and G. C. Sparagna (2007)
Am J Physiol Cell Physiol
292, C33-C44
|Abstract »|Full Text »|PDF »
p53 Mediates Nontranscriptional Cell Death in Dopaminergic Cells in Response to Proteasome Inhibition.
V. D. Nair, K. St. P. McNaught, J. Gonzalez-Maeso, S. C. Sealfon, and C. W. Olanow (2006)
J. Biol. Chem.
281, 39550-39560
|Abstract »|Full Text »|PDF »
Transgenic Rescue of ataxia Mice with Neuronal-Specific Expression of Ubiquitin-Specific Protease 14..
S. Crimmins, Y. Jin, C. Wheeler, A. K. Huffman, C. Chapman, L. E. Dobrunz, A. Levey, K. A. Roth, J. A. Wilson, and S. M. Wilson (2006)
J. Neurosci.
26, 11423-11431
|Abstract »|Full Text »|PDF »
{beta}-synuclein modulates {alpha}-synuclein neurotoxicity by reducing {alpha}-synuclein protein expression.
Y. Fan, P. Limprasert, I. V.J. Murray, A. C. Smith, V. M.-Y. Lee, J. Q. Trojanowski, B. L. Sopher, and A. R. La Spada (2006)
Hum. Mol. Genet.
15, 3002-3011
|Abstract »|Full Text »|PDF »
RTP801 Is Elevated in Parkinson Brain Substantia Nigral Neurons and Mediates Death in Cellular Models of Parkinson's Disease by a Mechanism Involving Mammalian Target of Rapamycin Inactivation.
C. Malagelada, E. J. Ryu, S. C. Biswas, V. Jackson-Lewis, and L. A. Greene (2006)
J. Neurosci.
26, 9996-10005
|Abstract »|Full Text »|PDF »
Overstimulation of PrPC Signaling Pathways by Prion Peptide 106-126 Causes Oxidative Injury of Bioaminergic Neuronal Cells.
M. Pietri, A. Caprini, S. Mouillet-Richard, E. Pradines, M. Ermonval, J. Grassi, O. Kellermann, and B. Schneider (2006)
J. Biol. Chem.
281, 28470-28479
|Abstract »|Full Text »|PDF »
The Role of G-Protein-Coupled Receptor Kinase 5 in Pathogenesis of Sporadic Parkinson's Disease.
S. Arawaka, M. Wada, S. Goto, H. Karube, M. Sakamoto, C.-H. Ren, S. Koyama, H. Nagasawa, H. Kimura, T. Kawanami, et al. (2006)
J. Neurosci.
26, 9227-9238
|Abstract »|Full Text »|PDF »
From the Cover: Antioxidants protect PINK1-dependent dopaminergic neurons in Drosophila.
D. Wang, L. Qian, H. Xiong, J. Liu, W. S. Neckameyer, S. Oldham, K. Xia, J. Wang, R. Bodmer, and Z. Zhang (2006)
PNAS
103, 13520-13525
|Abstract »|Full Text »|PDF »
A Potential Role for Cyclized Quinones Derived from Dopamine, DOPA, and 3,4-Dihydroxyphenylacetic Acid in Proteasomal Inhibition.
Mutational analysis of DJ-1 in Drosophila implicates functional inactivation by oxidative damage and aging.
M. C. Meulener, K. Xu, L. Thomson, H. Ischiropoulos, and N. M. Bonini (2006)
PNAS
103, 12517-12522
|Abstract »|Full Text »|PDF »
Endocrine signaling in Caenorhabditis elegans controls stress response and longevity..
R. Baumeister, E. Schaffitzel, and M. Hertweck (2006)
J. Endocrinol.
190, 191-202
|Abstract »|Full Text »|PDF »
Endogenous alpha-synuclein is induced by valproic acid through histone deacetylase inhibition and participates in neuroprotection against glutamate-induced excitotoxicity..
Mitochondrial pathology and muscle and dopaminergic neuron degeneration caused by inactivation of Drosophila Pink1 is rescued by Parkin.
Y. Yang, S. Gehrke, Y. Imai, Z. Huang, Y. Ouyang, J.-W. Wang, L. Yang, M. F. Beal, H. Vogel, and B. Lu (2006)
PNAS
103, 10793-10798
|Abstract »|Full Text »|PDF »
Identification of Far Upstream Element-binding Protein-1 as an Authentic Parkin Substrate.
H. S. Ko, S. W. Kim, S. R. Sriram, V. L. Dawson, and T. M. Dawson (2006)
J. Biol. Chem.
281, 16193-16196
|Abstract »|Full Text »|PDF »
Metabolism of 3-nitrotyrosine induces apoptotic death in dopaminergic cells..
B. Blanchard-Fillion, D. Prou, M. Polydoro, D. Spielberg, E. Tsika, Z. Wang, S. L. Hazen, M. Koval, S. Przedborski, and H. Ischiropoulos (2006)
J. Neurosci.
26, 6124-6130
|Abstract »|Full Text »|PDF »
Association of PINK1 and DJ-1 confers digenic inheritance of early-onset Parkinson's disease.
B. Tang, H. Xiong, P. Sun, Y. Zhang, D. Wang, Z. Hu, Z. Zhu, H. Ma, Q. Pan, J.-h. Xia, et al. (2006)
Hum. Mol. Genet.
15, 1816-1825
|Abstract »|Full Text »|PDF »
Caspase-3-derived C-terminal Product of Synphilin-1 Displays Antiapoptotic Function via Modulation of the p53-dependent Cell Death Pathway.
E. Giaime, C. Sunyach, M. Herrant, S. Grosso, P. Auberger, P. J. McLean, F. Checler, and C. A. da Costa (2006)
J. Biol. Chem.
281, 11515-11522
|Abstract »|Full Text »|PDF »
Basic fibroblast growth factor protects against rotenone-induced dopaminergic cell death through activation of extracellular signal-regulated kinases 1/2 and phosphatidylinositol-3 kinase pathways..
S.-L. Hsuan, H. M. Klintworth, and Z. Xia (2006)
J. Neurosci.
26, 4481-4491
|Abstract »|Full Text »|PDF »
Neuroprotection by transgenic expression of glucose-6-phosphate dehydrogenase in dopaminergic nigrostriatal neurons of mice..
R. Mejias, J. Villadiego, C. O. Pintado, P. J. Vime, L. Gao, J. J. Toledo-Aral, M. Echevarria, and J. Lopez-Barneo (2006)
J. Neurosci.
26, 4500-4508
|Abstract »|Full Text »|PDF »
Reactive Oxygen Species-Mediated Mitochondria-to-Nucleus Signaling: A Key to Aging and Radical-Caused Diseases.
6-Hydroxydopamine but Not 1-Methyl-4-phenylpyridinium Abolishes {alpha}-Synuclein Anti-apoptotic Phenotype by Inhibiting Its Proteasomal Degradation and by Promoting Its Aggregation.
C. A. da Costa, J. Dunys, F. Brau, S. Wilk, R. Cappai, and F. Checler (2006)
J. Biol. Chem.
281, 9824-9831
|Abstract »|Full Text »|PDF »
Inclusion body formation and neurodegeneration are parkin independent in a mouse model of alpha-synucleinopathy..
R. von Coelln, B. Thomas, S. A. Andrabi, K. L. Lim, J. M. Savitt, R. Saffary, W. Stirling, K. Bruno, E. J. Hess, M. K. Lee, et al. (2006)
J. Neurosci.
26, 3685-3696
|Abstract »|Full Text »|PDF »
Role of Ubiquitylation in Cellular Membrane Transport.
T. Kuwahara, A. Koyama, K. Gengyo-Ando, M. Masuda, H. Kowa, M. Tsunoda, S. Mitani, and T. Iwatsubo (2006)
J. Biol. Chem.
281, 334-340
|Abstract »|Full Text »|PDF »
Identification of Genes Related to Parkinson's Disease Using Expressed Sequence Tags.
J.-M. Kim, K.-H. Lee, Y.-J. Jeon, J.-H. Oh, S.-Y. Jeong, I.-S. Song, J.-M. Kim, D.-S. Lee, and N.-S. Kim (2006)
DNA Res
13, 275-286
|Abstract »|Full Text »|PDF »
Comparison of Structure and Dynamics of Micelle-bound Human {alpha}-Synuclein and Parkinson Disease Variants.
Glycogen Synthase Kinase 3beta Modulates Synphilin-1 Ubiquitylation and Cellular Inclusion Formation by SIAH: IMPLICATIONS FOR PROTEASOMAL FUNCTION AND LEWY BODY FORMATION.
E. Avraham, R. Szargel, A. Eyal, R. Rott, and S. Engelender (2005)
J. Biol. Chem.
280, 42877-42886
|Abstract »|Full Text »|PDF »
DJ-1 Up-regulates Glutathione Synthesis during Oxidative Stress and Inhibits A53T {alpha}-Synuclein Toxicity.
Leucine-rich repeat kinase 2 (LRRK2) interacts with parkin, and mutant LRRK2 induces neuronal degeneration.
W. W. Smith, Z. Pei, H. Jiang, D. J. Moore, Y. Liang, A. B. West, V. L. Dawson, T. M. Dawson, and C. A. Ross (2005)
PNAS
102, 18676-18681
|Abstract »|Full Text »|PDF »
Stress-induced alterations in parkin solubility promote parkin aggregation and compromise parkin's protective function.
C. Wang, H. S. Ko, B. Thomas, F. Tsang, K. C.M. Chew, S.-P. Tay, M. W.L. Ho, T.-M. Lim, T.-W. Soong, O. Pletnikova, et al. (2005)
Hum. Mol. Genet.
14, 3885-3897
|Abstract »|Full Text »|PDF »
Selenomethionine Prevents Degeneration Induced by Overexpression of Wild-Type Human {alpha}-Synuclein during Differentiation of Neuroblastoma Cells.
B. Kumar, P. Nahreini, A. J. Hanson, C. Andreatta, J. E. Prasad, and K. N. Prasad (2005)
J. Am. Coll. Nutr.
24, 516-523
|Abstract »|Full Text »|PDF »
Mitochondrial Lipid Abnormality and Electron Transport Chain Impairment in Mice Lacking {alpha}-Synuclein.
C. E. Ellis, E. J. Murphy, D. C. Mitchell, M. Y. Golovko, F. Scaglia, G. C. Barcelo-Coblijn, and R. L. Nussbaum (2005)
Mol. Cell. Biol.
25, 10190-10201
|Abstract »|Full Text »|PDF »
From The Cover: Parkinson's disease-associated mutations in leucine-rich repeat kinase 2 augment kinase activity.
A. B. West, D. J. Moore, S. Biskup, A. Bugayenko, W. W. Smith, C. A. Ross, V. L. Dawson, and T. M. Dawson (2005)
PNAS
102, 16842-16847
|Abstract »|Full Text »|PDF »
Intrasarcoplasmic Amyloidosis Impairs Proteolytic Function of Proteasomes in Cardiomyocytes by Compromising Substrate Uptake.
Q. Chen, J.-B. Liu, K. M. Horak, H. Zheng, A. R.K. Kumarapeli, J. Li, F. Li, A. M. Gerdes, E. F. Wawrousek, and X. Wang (2005)
Circ. Res.
97, 1018-1026
|Abstract »|Full Text »|PDF »
Present and future drug treatment for Parkinson's disease.
The G6055A (G2019S) mutation in LRRK2 is frequent in both early and late onset Parkinson's disease and originates from a common ancestor.
S Goldwurm, A D. Fonzo, E J Simons, C F Rohe, M Zini, M Canesi, S Tesei, A Zecchinelli, A Antonini, C Mariani, et al. (2005)
J. Med. Genet.
42, e65
|Abstract »|Full Text »|PDF »
Partial Mitochondrial Inhibition Causes Striatal Dopamine Release Suppression and Medium Spiny Neuron Depolarization via H2O2 Elevation, Not ATP Depletion.
L. Bao, M. V. Avshalumov, and M. E. Rice (2005)
J. Neurosci.
25, 10029-10040
|Abstract »|Full Text »|PDF »
Wild-type PINK1 Prevents Basal and Induced Neuronal Apoptosis, a Protective Effect Abrogated by Parkinson Disease-related Mutations.
A. Petit, T. Kawarai, E. Paitel, N. Sanjo, M. Maj, M. Scheid, F. Chen, Y. Gu, H. Hasegawa, S. Salehi-Rad, et al. (2005)
J. Biol. Chem.
280, 34025-34032
|Abstract »|Full Text »|PDF »
Dieldrin Induces Ubiquitin-Proteasome Dysfunction in {alpha}-Synuclein Overexpressing Dopaminergic Neuronal Cells and Enhances Susceptibility to Apoptotic Cell Death.
F. Sun, V. Anantharam, C. Latchoumycandane, A. Kanthasamy, and A. G. Kanthasamy (2005)
J. Pharmacol. Exp. Ther.
315, 69-79
|Abstract »|Full Text »|PDF »
Membrane Permeabilization: A Common Mechanism in Protein-Misfolding Diseases.
Inactivation of Drosophila DJ-1 leads to impairments of oxidative stress response and phosphatidylinositol 3-kinase/Akt signaling.
Y. Yang, S. Gehrke, Md. E. Haque, Y. Imai, J. Kosek, L. Yang, M. F. Beal, I. Nishimura, K. Wakamatsu, S. Ito, et al. (2005)
PNAS
102, 13670-13675
|Abstract »|Full Text »|PDF »
Investigating the Receptor-independent Neuroprotective Mechanisms of Nicotine in Mitochondria.
Y.-X. Xie, E. Bezard, and B.-L. Zhao (2005)
J. Biol. Chem.
280, 32405-32412
|Abstract »|Full Text »|PDF »
Accumulation of the Authentic Parkin Substrate Aminoacyl-tRNA Synthetase Cofactor, p38/JTV-1, Leads to Catecholaminergic Cell Death.
H. S. Ko, R. von Coelln, S. R. Sriram, S. W. Kim, K. K. K. Chung, O. Pletnikova, J. Troncoso, B. Johnson, R. Saffary, E. L. Goh, et al. (2005)
J. Neurosci.
25, 7968-7978
|Abstract »|Full Text »|PDF »
Tyrosine Phosphorylation Regulates the Proteolytic Activation of Protein Kinase C{delta} in Dopaminergic Neuronal Cells.
S. Kaul, V. Anantharam, Y. Yang, C. J. Choi, A. Kanthasamy, and A. G. Kanthasamy (2005)
J. Biol. Chem.
280, 28721-28730
|Abstract »|Full Text »|PDF »
Bcl-x Is Required for Proper Development of the Mouse Substantia Nigra.
J. M. Savitt, S. S. Jang, W. Mu, V. L. Dawson, and T. M. Dawson (2005)
J. Neurosci.
25, 6721-6728
|Abstract »|Full Text »|PDF »
Mitochondrial localization of the Parkinson's disease related protein DJ-1: implications for pathogenesis.
L. Zhang, M. Shimoji, B. Thomas, D. J. Moore, S.-W. Yu, N. I. Marupudi, R. Torp, I. A. Torgner, O. P. Ottersen, T. M. Dawson, et al. (2005)
Hum. Mol. Genet.
14, 2063-2073
|Abstract »|Full Text »|PDF »
-synuclein aggregation, which contributes to the demise of dopamine neurons. Accumulation and aggregation of 
